Wednesday, March 07, 2012
Friday, February 17, 2012
-
Gilead Falls On Disappointing Hep C Drug Data; Analysts Remain Bullish (ACHN, Analyst Color, BMY, C, GILD, IDIX, JPM, News, VRTX, Small Cap, FDA, Events, Intraday Update, Analyst Ratings, Movers / Fri, 01:30pm)
Thursday, January 19, 2012
Tuesday, January 17, 2012
-
S&P Lukewarm On New Low Volatility ETFs (Analyst Color, BMY, GIS, KMB, Long Ideas, LVOL, News, PAYX, PG, SPLV, USMV, Broad U.S. Equity ETFs, Short Ideas, Specialty ETFs, New ETFs, Initiation, Intraday Update, Markets, Analyst Ratings, Trading Ideas, ETFs / Tue, 02:23pm)
Friday, January 13, 2012
Tuesday, January 10, 2012
-
Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target? (ABT, ACHN, BMY, GILD, IDIX, INHX, JNJ, Long Ideas, MRK, News, NVS, PFE, VRTX, VRUS, Short Ideas, Price Target, Rumors, M&A, Events, Intraday Update, Analyst Ratings, Movers, Trading Ideas / Tue, 03:54pm)
Monday, January 09, 2012
-
Bank of America Raises PO on Idenix Pharmaceuticals to $18 (Analyst Color, BMY, IDIX, INHX, News, Price Target, M&A, Analyst Ratings / Mon, 11:14am)
-
Financial Breakfast: Morning News Summary for January 9, 2012 (ANF, BMY, Earnings, EBS, INHX, INSP, MR, News, NFLX, SPRD, TRV, Futures, Guidance, Upgrades, Commodities, Downgrades, Forex, Technicals, FDA, M&A, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Tech, Trading Ideas, General / Mon, 08:26am)
-
Brean Murray Raises PT on Inhibitex to $26 (BMY, INHX, News, Price Target, M&A, Pre-Market Outlook, Analyst Ratings / Mon, 07:55am)
Wednesday, January 04, 2012
Friday, December 23, 2011
Thursday, December 08, 2011
Tuesday, November 29, 2011
-
Bank of America Reiterates Neutral on Bristol-Myers Squibb (Analyst Color, BMY, News, Reiteration, FDA, Analyst Ratings / Tue, 12:08pm)
-
Deutsche Bank Reiterates Buy on Bristol-Myers Squibb (Analyst Color, BMY, Reiteration, Analyst Ratings / Tue, 11:55am)
Wednesday, November 16, 2011
Monday, November 14, 2011
-
ISI Group Publishes Report on Bristol-Myers Squibb (Analyst Color, BMY, Analyst Ratings / Mon, 09:00am)
-
Financial Breakfast: Morning News Summary for November 14, 2011 (BA, BAC, BMY, CRM, DYN, Earnings, EV, GRRF, IBM, KSU, Long Ideas, LOW, News, PFE, TSN, Guidance, Short Ideas, Upgrades, Downgrades, Movers & Shakers, Financing, Technicals, Offerings, Asset Sales, Events, Global, Econ #s, Economics, Pre-Market Outlook, Analyst Ratings, Trading Ideas, General / Mon, 08:48am)
Thursday, October 27, 2011
-
Financial Breakfast: Morning News Summary for October 27, 2011 (ABX, BMY, CSCO, DOW, DTG, Earnings, ERIC, HS, HSP, HTZ, Long Ideas, MO, News, PG, RTN, SNE, TMO, UAL, Futures, Guidance, Short Ideas, Upgrades, Commodities, Downgrades, Forex, Technicals, Buybacks, M&A, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General / Thu, 07:55am)
Wednesday, October 05, 2011
-
Bank of America Raises PO on Bristol-Myers Squibb to $34 (BMY, Price Target, Analyst Ratings / Wed, 06:12am)
Monday, September 26, 2011
Thursday, September 22, 2011
Monday, September 19, 2011
-
Benzinga's Top Upgrades (BMY, CRH, MU, WCRX, Upgrades, Analyst Ratings / Mon, 07:32am)
Monday, August 29, 2011
-
J.P. Morgan Maintains Neutral on Bristol-Myers Squibb (Analyst Color, BMY, Analyst Ratings / Mon, 09:40am)
-
Bank of America Raises PO On Bristol-Myers Squibb To $32 (BMY, Price Target, Analyst Ratings / Mon, 05:54am)
Tuesday, August 02, 2011
-
Citigroup Raises PT On Bristol-Myers Squibb To $39 (BMY, Price Target, Analyst Ratings / Tue, 06:07am)
Wednesday, July 20, 2011
-
Jefferies Reports FDA Votes Against BMY Dapagliflozin Approval (Analyst Color, BMY, CRL, Analyst Ratings / Wed, 07:47am)
-
ISI Provides Color on Bristol Myers Squibb (Analyst Color, BMY, Analyst Ratings / Wed, 03:00am)
Monday, July 18, 2011
-
Deutsche Bank Provides Color on Pharmaceuticals (Analyst Color, BMY, MRK, PFE, Analyst Ratings / Mon, 08:15am)
-
Jefferies Lowers PT On Bristol-Myers Squibb To $27 (BMY, Price Target, Analyst Ratings / Mon, 07:12am)
Monday, July 11, 2011
-
Citi Maintains Buy on Bristol-Myers Squibb (Analyst Color, BMY, Analyst Ratings / Mon, 08:11am)
